C Ingvar
Overview
Explore the profile of C Ingvar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Grabau D, Dihge L, Ferno M, Ingvar C, Ryden L
Eur J Surg Oncol
. 2013 Apr;
39(6):601-7.
PMID: 23579175
Background: The need for completion axillary lymph node dissection (ALND) in breast cancer patients with micrometastases in the sentinel nodes (SNs) is controversial. The aim of this retrospective observational study...
12.
Lyth J, Hansson J, Ingvar C, Mansson-Brahme E, Naredi P, Stierner U, et al.
Br J Dermatol
. 2012 Oct;
168(4):779-86.
PMID: 23066913
Background: Survival and prognostic factors for thin melanomas have been studied relatively little in population-based settings. This patient group accounts for the majority of melanomas diagnosed in western countries today,...
13.
Andersson Y, de Boniface J, Jonsson P, Ingvar C, Liljegren G, Bergkvist L, et al.
Br J Surg
. 2011 Dec;
99(2):226-31.
PMID: 22180063
Background: Sentinel lymph node (SLN) biopsy has replaced axillary lymph node dissection (ALND) as the standard axillary staging procedure in breast cancer. Follow-up studies in SLN-negative women treated without ALND...
14.
Lundin K, Henningson M, Hietala M, Ingvar C, Rose C, Jernstrom H
Br J Cancer
. 2011 Oct;
105(11):1676-83.
PMID: 22033271
Background: The androgen receptor (AR) is frequently expressed in breast cancers. The AR genotype may affect disease-free survival and response to endocrine therapy. Methods: In all, 634 women undergoing breast...
15.
Chakera A, Nielsen B, Madsen J, Romer J, Kristjansen P, Buch I, et al.
Int J Mol Imaging
. 2011 May;
2011:828151.
PMID: 21603241
Aim. To develop a method and obtain proof-of-principle for immunolymphoscintigraphy for identification of metastatic sentinel nodes. Methods. We selected one of four tumour-specific antibodies against human breast cancer and investigated...
16.
Clonal chromosome-aberrations in fibrocystic breast disease-associated with increased risk of cancer
Petersson C, Johansson B, Pandis N, Gorunova L, Ingvar C, Idvall I, et al.
Int J Oncol
. 2011 May;
5(6):1207-10.
PMID: 21559699
Short-term cultures of 29 samples of fibrocystic breast disease were cytogenetically analyzed. Clonal chromosome aberrations were found in six specimens, whereas the remaining 23 had a normal karyotype. Three of...
17.
Demenais F, Mohamdi H, Chaudru V, Goldstein A, Newton Bishop J, Bishop D, et al.
J Natl Cancer Inst
. 2010 Sep;
102(20):1568-83.
PMID: 20876876
Background: Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associated with a high risk for melanoma. Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes, and...
18.
Jernstrom H, Bageman E, Rose C, Jonsson P, Ingvar C
Br J Cancer
. 2009 Nov;
101(11):1817-23.
PMID: 19935798
Background: CYP2C8/9 polymorphisms may influence breast cancer-free survival after diagnosis due to their role in the metabolism of tamoxifen, paclitaxel, and other chemotherapy. cytochrome P450 (CYP)2C8/9 metabolise arachidonic acid to...
19.
Haraldsdottir K, Ivarsson K, Gotberg S, Ingvar C, Stenram U, Tranberg K
Eur J Surg Oncol
. 2008 Feb;
34(7):739-45.
PMID: 18291614
Aim: To find out if ILT can be used as radical treatment of breast cancer. Method: Twenty-four patients, aged 39-84 (mean 61), with invasive breast cancer were treated with ILT....
20.
Nielsen K, Masback A, Bladstrom A, Lundgren L, Jonsson N, Borg A, et al.
Br J Dermatol
. 2007 Dec;
158(2):429-31.
PMID: 18047508
No abstract available.